Clinical Trial Update: A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial to evaluate the effects of VHB937 in people with amyotrophic lateral sclerosis is active but not currently recruiting. The study is spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• VHB937

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Status: ACTIVE_NOT_RECRUITING